Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Income from Continuing Operations (2022 - 2025)

CervoMed (CRVO) has disclosed Income from Continuing Operations for 9 consecutive years, with 8090581.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 20.6% to 8090581.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 26958040.0 through Dec 2025, down 65.49% year-over-year, with the annual reading at 26958040.0 for FY2025, 65.49% down from the prior year.
  • Income from Continuing Operations hit 8090581.0 in Q4 2025 for CervoMed, down from 7725412.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1213290.0 in Q2 2023 to a low of 8090581.0 in Q4 2025.
  • Historically, Income from Continuing Operations has averaged 4152039.81 across 4 years, with a median of 4133232.5 in 2022.
  • Biggest five-year swings in Income from Continuing Operations: soared 71.05% in 2023 and later plummeted 184.05% in 2024.
  • Year by year, Income from Continuing Operations stood at 4075964.0 in 2022, then surged by 42.06% to 2361798.0 in 2023, then plummeted by 184.05% to 6708640.0 in 2024, then dropped by 20.6% to 8090581.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for CRVO at 8090581.0 in Q4 2025, 7725412.0 in Q3 2025, and 6248148.0 in Q2 2025.